TRACON Pharmaceuticals, Inc.
TCON
|
NASDAQ
|
0 Followers
Company Quality
Profitability Score
50/100
Solvency Score
25/100
Dividends
Dividends data currently unavailable.Earnings
8/11/2025
in 63 days
-
Revenue est.
-
EPS est.
My Notes
You haven't added any notes for this stock yet. Use this space to record your insights or strategies.
Profile
Healthcare
Sector
Biotechnology
Industry
Mr. Craig R. Jalbert CIRA
CEO
17
Employees
San Diego
Headquarters
US
Country
Key Metrics TTM
Valuation
Market cap.
$110KEnterprise Value
-$6.2MPrice to Earnings
-0.02Price to Sales
0.03Price to Book
-0.03Price to Cash Flow
-0.02Profitability
Return on Assets
-75.24%Return on Equity
295.12%Return on Invested Capital
130.49%Gross Margin
99.78%Operating Margin
-178.66%Net Margin
-174.00%Liquidity
Quick Ratio
0.66Current Ratio
0.66Cash Ratio
0.63Inventory Turnover
0.00Asset Turnover
0.43Total Liabilities
$10MSolvency
Debt to Assets
0.00Debt to Equity
N/AInterest Coverage
-107.9Equity Ratio
-0.42Long-term Debt to Cap.
0.00Altman Z-Score
-44.21Performance
Performance data currently unavailable.
Earnings Waterfall
Debt level and coverage
Debt level and coverage data currently unavailable.
Earnings
Feed
There are no posts to show right now.